![](/img/cover-not-exists.png)
PCN2 COST-EFFECTIVENESS OF IMATINIB (GLEEVEC)AS FIRST-LINE TREATMENT IN CHRONIC MYELOID LEUKEMIA (CML)
K El Ouagari, W Talbot, JF BaladiVolume:
7
Year:
2004
Language:
english
DOI:
10.1016/s1098-3015(10)65736-1
File:
PDF, 64 KB
english, 2004